These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26410289)

  • 21. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sweat chloride and immunoreactive trypsinogen in infants carrying two
    Castellani C; Tridello G; Tamanini A; Assael BM
    Arch Dis Child; 2017 Jul; 102(7):644-646. PubMed ID: 26755536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory System Disease.
    Goetz DM; Singh S
    Pediatr Clin North Am; 2016 Aug; 63(4):637-59. PubMed ID: 27469180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral spontaneous pneumothorax in a newborn with N1303K mutation of cystic fibrosis (CFTR) gene.
    Ataseven F; Ozer S; Yılmaz R; Senaylı A
    Tuberk Toraks; 2010; 58(2):181-3. PubMed ID: 20865572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis: experience in one institution.
    Liu LC; Shyur SD; Chu SH; Huang LH; Kao YH; Lei WT; Cheng CH; Lo CY; Chen CK; Fang LC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):358-61. PubMed ID: 22992393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the diagnosis and therapy of diabetes mellitus in cystic fibrosis.
    Riggs AC; Seaquist ER; Moran A
    Curr Opin Pulm Med; 1999 Nov; 5(6):378-82. PubMed ID: 10570740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational spectrum of cystic fibrosis in the Lebanese population.
    Farra C; Menassa R; Awwad J; Morel Y; Salameh P; Yazbeck N; Majdalani M; Wakim R; Yunis K; Mroueh S; Cabet F
    J Cyst Fibros; 2010 Dec; 9(6):406-10. PubMed ID: 20797923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic involvement in cystic fibrosis.
    Ozen Alahdab Y; Duman DG
    Minerva Med; 2016 Dec; 107(6):427-436. PubMed ID: 27425634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory tests for the diagnosis of cystic fibrosis.
    Wang L; Freedman SD
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S109-15. PubMed ID: 14569807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Consensus on the diagnosis and management of changes in carbohydrate metabolism in cystic fibrosis].
    Barrio Castellanos R ; Cos Blanco A ; García García E ; Gussinyé Cañadell M ; Merino Torres J ; Muñoz Calvo M
    An Esp Pediatr; 2000 Dec; 53(6):573-9. PubMed ID: 11148156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CFTR gene analysis in cystic fibrosis patients: detection of 91% of molecular defects and identification of the novel mutation D979V.
    Plouvier E; Cougoureux E; Sardet A; Tournier G; Aymard P; Feldmann D
    Ann Genet; 1997; 40(3):185-8. PubMed ID: 9401110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case report of cystic fibrosis and review of 16 cases of cystic fibrosis in Chinese patients].
    Li N; He B; Wang GF; Tang XY
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep; 26(9):559-62. PubMed ID: 14521762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
    Yang H; Ma T
    Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CFTR: Ferreting Out Its Role in Cystic Fibrosis-Related Diabetes.
    Satin LS; Parekh VS
    Endocrinology; 2017 Oct; 158(10):3319-3321. PubMed ID: 28977616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.